SCHEMBL7919541

SCHEMBL7919541

COCCOc1ccc(CC(=O)NC(C)=O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.54
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ PDE4A P27815 1/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ HDAC10 Q969S8 1/20 0.54
▸ HDAC6 Q9UBN7 1/20 0.54
▸ ACACB O00763 2/20 0.52
▸ ALDH1A1 P00352 3/20 0.49
▸ LMNA P02545 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ CACNA1H O95180 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MTNR1A P48039 1/20 0.45
▸ MTNR1B P49286 1/20 0.45
▸ MAPK1 P28482 1/20 0.44
▸ MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7905684 0.86 SMN1; SMN2 (0.55) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL7913801 0.85 SMN1; SMN2 (0.54) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL7919550 0.84 KDM4E (0.52) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL7916079 0.83 SMN1; SMN2 (0.57) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL7905681 0.82 HTT (0.71) SMN1; SMN2ALDH1A1LMNAHTTMAPT
SCHEMBL874241 0.82 POLB (0.54) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL7917566 0.81 ALDH1A1 (0.55) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL10076459 0.81 ALDH1A1 (0.55) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL7915995 0.81 KDM4E (0.52) KDM4ESMN1; SMN2CYP1A2CYP2D6PDE4A
SCHEMBL7915934 0.80 MAPT (0.59) KDM4ESMN1; SMN2ACACBALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010048340-A2 NOVEL SEMI-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS LEAD THERAPEUTICS, INC. (US) 2010-04-29 — — WO disclosed
Send feedback